Obstetric and Neonatal Outcome in PCOS with Gestational Diabetes Mellitus
Abstract
Objective: There are some metabolic similarities between women with gestational diabetes mellitus (GDM) and polycystic ovary syndrome (PCOS); it is still uncertain, however, to what extent coexistence GDM and PCOS affects pregnancy outcome. The present study was designed to determine the obstetric and neonatal outcome in PCOS with GDM.
Materials and methods:A case-control study was conducted involving 261 GDM women. Thirty hundred-one cases had PCOS based on Rotterdam criteria and the other thirty hundred cases (control group) were women without PCOS. The subjects in each group were evaluated regarding obstetric and those women whose documentation's were complete entered the study.
Results:In present study, women with PCOS and GDM had more than twofold increased odds of preeclampsia (p = 0.003, CI = 1.56-5.01, and OR = 2.8) and PIH (p= 0.04, CI = 1.28-4.5, and OR= 2.4). Maternal PCOS and GDM were also associated with threefold increased odds of neonatal hypoglycemia (p= 0.004, CI= 1.49-6.58, and OR= 3.13).
Conclusion:Our finding emphasized that pregnant PCOS patients should be followed carefully for the occurrence of various pregnancy and neonatal complications including hypertension and hypoglycemia. We suggested that these neonates should be given more care regarding hypoglycemia symptoms.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–36.
Hahn S, Janssen OE, Tan S, Pleger K, Mann K, chedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Euro J Endocrinol 2005;153:853-60.
Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO, et a, l. Women with polycystic ovary syndrome wedge resected in 1956-65:a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992;57:505-13.
Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod 2003;18:1438-41.
Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style? J Endocrinol Invest 1998;21:589-601.
Jensen RB, Chellakooty M, Vielwerth S, Vaag A, Larsen T, Greisen G, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role? Horm Res2003;60((Suppl 3)):136-48.
Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16:226-9.
Turhan NO, Seckin NC, Aybar F, Inegol I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet 2003;81:163-8.
Koivunen RM, Juutinen J, Vauhkonen I, Morin- Papunen LC, Ruokonen A, Tapanainen JS. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab 2001;86:2591-9.
Kousta E, Cela E, Lawrence N, Penny A, Millauer B, White D, et al. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf) 2000;53:501-7.
Holte J, Gennarelli G, Wide L, Lithell H, Berne C. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 1998;83:1143-50.
Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S. Differential androgene response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion. Fertil Steril 1992;58:296-301.
Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovaries. Hum Reprod 2000;15:1266-74.
Lankarani M, ValiZade N, Heshmat R, Shafaee A, Amini MR,Noori M,et al. Evaluation of dyslipidemia in polycystic ovary syndrome. Iranian Journal of Diabetes and Lipid Disorders 2005;2:79-88.
Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87:524-9.
Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage-a reappraisal. Hum Reprod 2000;15:612-5.
Sugiura-Ogasawara M, Sato T, Suzumori N, Kitaori T, Kumagai K, Ozaki Y. The polycystic ovary syndrome does not predict further miscarriage in Japanese couples experiencing recurrent miscarriages. Am J Reprod Immunol 2009;61:62-7.
Urman B, Sarac E, Dogan L, Gurgan T. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 1997;42:501-5.
De Boo HA, Harding JE. The developmental origins of adult disease (Barker) hypothesi. Aust N Z J Obstet Gynaecol 2006;46:4-14.
Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72-84 .
Metzger BE. Summary and recommendations of the third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Annual1991;40:197-201.
Stephnson MJ. Screening of diabetes mellitus: a critical review. J Fam Pract 1993;37:277-83.
Hadden DR. Geographic, ethnic and racial variations in the incidence of Gestational diabetes mellitus. Diabetes Annual 1985;34:8 - 12.
O'Sullivan JB. The interaction between pregnancy, diabetes and long-term maternal outcome, Diabetes Mellitus in Pregnancy. 2nd Ed, New York: Churchill Livingstone1995:389- 98.
Johnston DG, Beard RW, Chan SP, Dornhorst A, Elkeles RS, Gelding SV, et al. Aspects of metabolism in normal and gestational diabetic pregnancy. Biochem Soc Transact 1995;23:512-6.
Ferrara A, Hedderson MM, Quesenberry CP, Selby JV. Prevalence of gestational diabetes mellitus detected by the National Diabetes Data Group or the Carpenter and Coustan plasma glucose thresholds. Diabetes Care 2002;25:1625.
Ramezani Tehrani F, Simbar M, Tohidi M, Hosseinpanah F, Azizim F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive Biology and Endocrinology 2011;9:39.
Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Siba iBM, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998;179:1032-7.
Siassakos D, Wardle P. Polycystic ovary syndrome and pregnancy outcome: red herring or red flag? BJOG 2007;8:922-32.
Palomba S, Falbo A, Russo T, Battista L, Tolino A, Orio F, et al. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes. BJOG 2010;117:711-21.
Jensen RB, Chellakooty M, Vielwerth S, Vaag A, Larsen T, Greisen G, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life:does insulin-like growth factor-I play a role? Horm Res 2003;60(Suppl 3):136-48.
| Files | ||
| Issue | Vol 8, No 1 (March 2014) | |
| Section | Original Articles | |
| Keywords | ||
| Gestational Diabetes Mellitus (GDM) Hypoglycemia Polycystic Ovarian Syndrome (PCOS) Preeclampsia | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
